Serina Therapeutics (SER) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Serina Therapeutics (SER) over the last 9 years, with Q3 2025 value amounting to -$8.8 million.
- Serina Therapeutics' Enterprise Value fell 17000.61% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.8 million, marking a year-over-year decrease of 17000.61%. This contributed to the annual value of -$3.8 million for FY2024, which is 11321.87% down from last year.
- Serina Therapeutics' Enterprise Value amounted to -$8.8 million in Q3 2025, which was down 17000.61% from -$6.2 million recorded in Q2 2025.
- Over the past 5 years, Serina Therapeutics' Enterprise Value peaked at $28.8 million during Q4 2023, and registered a low of -$8.8 million during Q3 2025.
- Moreover, its 5-year median value for Enterprise Value was -$748000.0 (2022), whereas its average is -$1.0 million.
- Per our database at Business Quant, Serina Therapeutics' Enterprise Value soared by 394826.2% in 2023 and then tumbled by 201824.82% in 2024.
- Over the past 5 years, Serina Therapeutics' Enterprise Value (Quarter) stood at -$643000.0 in 2021, then fell by 16.33% to -$748000.0 in 2022, then surged by 3948.26% to $28.8 million in 2023, then plummeted by 113.22% to -$3.8 million in 2024, then tumbled by 130.91% to -$8.8 million in 2025.
- Its Enterprise Value was -$8.8 million in Q3 2025, compared to -$6.2 million in Q2 2025 and -$4.4 million in Q1 2025.